Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Apr;70(4):2116–2123. doi: 10.1128/jvi.70.4.2116-2123.1996

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

J Gall 1, A Kass-Eisler 1, L Leinwand 1, E Falck-Pedersen 1
PMCID: PMC190048  PMID: 8642632

Abstract

The efficient uptake of adenovirus into a target cell is a function of adenovirus capsid proteins and their interaction with the host cell. The capsid protein fiber mediates high-affinity attachment of adenovirus to the target cell. Although the cellular receptor(s) for adenovirus is unknown, evidence indicates that a single receptor does not function as the attachment site for each of the 49 different serotypes of adenovirus. Sequence variation of the fiber ligand, particularly in the C- terminal knob domain, is associated with serotype-specific binding specificity. Additionally, this domain of fiber functions as a major serotype determinant. Fiber involvement in cell targeting and its function as a target of the host immune response make the fiber gene an attractive target for manipulation, both from the perspective of adenovirus biology and from the perspective of using adenovirus vectors for gene transfer experiments. We have constructed a defective chimeric adenovirus type 5 (Ad5) reporter virus by replacing the Ad5 fiber gene with the fiber gene from Ad7A. Using the chloramphenicol acetyltransferase reporter gene, we have characterized this virus with respect to infectivity both in vitro and in vivo. We have also characterized the role of antifiber antibody in the host neutralizing immune response to adenovirus infection. Our studies demonstrate that exchange of fiber is a strategy that will be useful in characterizing receptor tropism for different serotypes of adenovirus. Additionally, the neutralizing immune response to Ad5 and Ad7 does not differentiate between two viruses that differ only in their fiber proteins. Therefore, following a primary adenovirus inoculation, antibodies generated against fiber do not constitute a significant fraction of the neutralizing antibody population.

Full Text

The Full Text of this article is available as a PDF (375.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bai M., Campisi L., Freimuth P. Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2. J Virol. 1994 Sep;68(9):5925–5932. doi: 10.1128/jvi.68.9.5925-5932.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bai M., Harfe B., Freimuth P. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol. 1993 Sep;67(9):5198–5205. doi: 10.1128/jvi.67.9.5198-5205.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Banks P. A., Kasel J. A., Huber M., Alford R. H., Knight V. Persistence of neutralizing antibody in adult volunteers immunized with adnovirus soluble antigens. Proc Soc Exp Biol Med. 1966 Jan;121(1):240–243. doi: 10.3181/00379727-121-30747. [DOI] [PubMed] [Google Scholar]
  4. Dai Y., Schwarz E. M., Gu D., Zhang W. W., Sarvetnick N., Verma I. M. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1401–1405. doi: 10.1073/pnas.92.5.1401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Defer C., Belin M. T., Caillet-Boudin M. L., Boulanger P. Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J Virol. 1990 Aug;64(8):3661–3673. doi: 10.1128/jvi.64.8.3661-3673.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977 Jul;36(1):59–74. doi: 10.1099/0022-1317-36-1-59. [DOI] [PubMed] [Google Scholar]
  7. Greber U. F., Willetts M., Webster P., Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell. 1993 Nov 5;75(3):477–486. doi: 10.1016/0092-8674(93)90382-z. [DOI] [PubMed] [Google Scholar]
  8. Green N. M., Wrigley N. G., Russell W. C., Martin S. R., McLachlan A. D. Evidence for a repeating cross-beta sheet structure in the adenovirus fibre. EMBO J. 1983;2(8):1357–1365. doi: 10.1002/j.1460-2075.1983.tb01592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henry L. J., Xia D., Wilke M. E., Deisenhofer J., Gerard R. D. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J Virol. 1994 Aug;68(8):5239–5246. doi: 10.1128/jvi.68.8.5239-5246.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hong J. S., Mullis K. G., Engler J. A. Characterization of the early region 3 and fiber genes of Ad7. Virology. 1988 Dec;167(2):545–553. [PubMed] [Google Scholar]
  11. Kass-Eisler A., Falck-Pedersen E., Alvira M., Rivera J., Buttrick P. M., Wittenberg B. A., Cipriani L., Leinwand L. A. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11498–11502. doi: 10.1073/pnas.90.24.11498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kass-Eisler A., Falck-Pedersen E., Elfenbein D. H., Alvira M., Buttrick P. M., Leinwand L. A. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1994 Nov;1(6):395–402. [PubMed] [Google Scholar]
  13. Kidd A. H., Chroboczek J., Cusack S., Ruigrok R. W. Adenovirus type 40 virions contain two distinct fibers. Virology. 1993 Jan;192(1):73–84. doi: 10.1006/viro.1993.1009. [DOI] [PubMed] [Google Scholar]
  14. Kjellén L., Pereira H. G. Role of adenovirus antigens in the induction of virus neutralizing antibody. J Gen Virol. 1968 Jan;2(1):177–185. doi: 10.1099/0022-1317-2-1-177. [DOI] [PubMed] [Google Scholar]
  15. Lonberg-Holm K., Philipson L. Early events of virus-cell interaction in an adenovirus system. J Virol. 1969 Oct;4(4):323–338. doi: 10.1128/jvi.4.4.323-338.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Louis N., Fender P., Barge A., Kitts P., Chroboczek J. Cell-binding domain of adenovirus serotype 2 fiber. J Virol. 1994 Jun;68(6):4104–4106. doi: 10.1128/jvi.68.6.4104-4106.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mathias P., Wickham T., Moore M., Nemerow G. Multiple adenovirus serotypes use alpha v integrins for infection. J Virol. 1994 Oct;68(10):6811–6814. doi: 10.1128/jvi.68.10.6811-6814.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mautner V., Willcox H. N. Adenovirus antigens: a model system in mice for subunit vaccination. J Gen Virol. 1974 Dec;25(3):325–336. doi: 10.1099/0022-1317-25-3-325. [DOI] [PubMed] [Google Scholar]
  19. Norrby E. Capsid mosaics of intermediate strains of human adenoviruses. J Virol. 1969 Nov;4(5):657–662. doi: 10.1128/jvi.4.5.657-662.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Norrby E., Gollmar Y. Mosaics of capsid components produced by cocultivation of certain human adenoviruses in vitro. Virology. 1971 May;44(2):383–395. doi: 10.1016/0042-6822(71)90269-8. [DOI] [PubMed] [Google Scholar]
  21. Norrby E., Marusyk H., Hammarskjöld M. L. The relationship between the soluble antigens and the virion of adenovirus type 3. V. Identification of antigen specificities available at the surface of virions. Virology. 1969 Jul;38(3):477–482. doi: 10.1016/0042-6822(69)90161-5. [DOI] [PubMed] [Google Scholar]
  22. Persson R., Wohlfart C., Svensson U., Everitt E. Virus-receptor interaction in the adenovirus system: characterization of the positive cooperative binding of virions on HeLa cells. J Virol. 1985 Apr;54(1):92–97. doi: 10.1128/jvi.54.1.92-97.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pettersson U., Philipson L., Höglund S. Structural proteins of adenoviruses. II. Purification and characterization of the adenovirus type 2 fiber antigen. Virology. 1968 Jun;35(2):204–215. doi: 10.1016/0042-6822(68)90261-4. [DOI] [PubMed] [Google Scholar]
  24. Philipson L., Lonberg-Holm K., Pettersson U. Virus-receptor interaction in an adenovirus system. J Virol. 1968 Oct;2(10):1064–1075. doi: 10.1128/jvi.2.10.1064-1075.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Praszkier J., Ginsberg H. S. Isolation and characterization of temperature-sensitive mutants of adenovirus type 7. J Virol. 1987 Oct;61(10):3089–3095. doi: 10.1128/jvi.61.10.3089-3095.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schaack J., Ho W. Y., Freimuth P., Shenk T. Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA. Genes Dev. 1990 Jul;4(7):1197–1208. doi: 10.1101/gad.4.7.1197. [DOI] [PubMed] [Google Scholar]
  27. Stevenson S. C., Rollence M., White B., Weaver L., McClelland A. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J Virol. 1995 May;69(5):2850–2857. doi: 10.1128/jvi.69.5.2850-2857.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Svensson U., Persson R. Entry of adenovirus 2 into HeLa cells. J Virol. 1984 Sep;51(3):687–694. doi: 10.1128/jvi.51.3.687-694.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Svensson U. Role of vesicles during adenovirus 2 internalization into HeLa cells. J Virol. 1985 Aug;55(2):442–449. doi: 10.1128/jvi.55.2.442-449.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Varga M. J., Weibull C., Everitt E. Infectious entry pathway of adenovirus type 2. J Virol. 1991 Nov;65(11):6061–6070. doi: 10.1128/jvi.65.11.6061-6070.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. WILCOX W. C., GINSBERG H. S. PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS. Proc Soc Exp Biol Med. 1963 Oct;114:37–42. doi: 10.3181/00379727-114-28579. [DOI] [PubMed] [Google Scholar]
  32. Wadell G. Sensitization and neutralization of adenovirus by specific sera against capsid subunits. J Immunol. 1972 Mar;108(3):622–632. [PubMed] [Google Scholar]
  33. Wickham T. J., Filardo E. J., Cheresh D. A., Nemerow G. R. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol. 1994 Oct;127(1):257–264. doi: 10.1083/jcb.127.1.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wickham T. J., Mathias P., Cheresh D. A., Nemerow G. R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993 Apr 23;73(2):309–319. doi: 10.1016/0092-8674(93)90231-e. [DOI] [PubMed] [Google Scholar]
  35. Willcox N., Mautner V. Antigenic determinants of adenovirus capsids. I. Measurement of antibody cross-reactivity. J Immunol. 1976 Jan;116(1):19–24. [PubMed] [Google Scholar]
  36. Wohlfart C. E., Svensson U. K., Everitt E. Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera. J Virol. 1985 Dec;56(3):896–903. doi: 10.1128/jvi.56.3.896-903.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wohlfart C. Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J Virol. 1988 Jul;62(7):2321–2328. doi: 10.1128/jvi.62.7.2321-2328.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yang Y., Li Q., Ertl H. C., Wilson J. M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 1995 Apr;69(4):2004–2015. doi: 10.1128/jvi.69.4.2004-2015.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Younghusband H. B., Maundrell K. Adenovirus DNA is associated with the nuclear matrix of infected cells. J Virol. 1982 Aug;43(2):705–713. doi: 10.1128/jvi.43.2.705-713.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES